These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25147315)

  • 21. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
    Canuso CM; Youssef EA; Bossie CA; Turkoz I; Schreiner A; Simpson GM
    Int Clin Psychopharmacol; 2008 Jul; 23(4):209-15. PubMed ID: 18545059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report.
    Angelucci F; Ricci V; Martinotti G; Caltagirone C; Bria P
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1277-8. PubMed ID: 19555731
    [No Abstract]   [Full Text] [Related]  

  • 23. [Non-fatal paliperidone overdose: a case report].
    Gill JS; Pillai SK; Koh OH; Jambunathan S
    Turk Psikiyatri Derg; 2010; 21(4):331-4. PubMed ID: 21125508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Delusional parasitosis: case report].
    Jakuszkowiak-Wojten K; Cubała WJ; Szeliga-Lewińska J
    Psychiatr Pol; 2007; 41(4):571-8. PubMed ID: 18046987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delusional infestation responding to blonanserin.
    Bhatia MS; Rathi A; Jhanjee A
    J Neuropsychiatry Clin Neurosci; 2013; 25(4):E54. PubMed ID: 24247894
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease.
    Amatniek J; Canuso CM; Deutsch SI; Henderson DC; Mao L; Mikesell C; Rodriguez S; Sheehan J; Alphs L
    Clin Schizophr Relat Psychoses; 2014 Apr; 8(1):8-20. PubMed ID: 23428785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive entomological survey and evaluation of the efficacy of different therapies on a suspected delusional parasitosis case.
    Soltan-Alinejad P; Vahedi M; Turki H; Soltani A
    Brain Behav; 2021 Jan; 11(1):e01945. PubMed ID: 33174366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy.
    Freudenmann RW; Lepping P
    J Clin Psychopharmacol; 2008 Oct; 28(5):500-8. PubMed ID: 18794644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Understanding and Approach to Delusional Infestation.
    Moriarty N; Alam M; Kalus A; O'Connor K
    Am J Med; 2019 Dec; 132(12):1401-1409. PubMed ID: 31295443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delusional infestations: case series, differential diagnoses, and management strategies.
    Diaz JH; Nesbitt LT
    J La State Med Soc; 2014; 166(4):154-9. PubMed ID: 25311458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delusional infestation successfully controlled with typical antipsychotic depot injection: An illustrative case report.
    Jamaluddin R
    Asian J Psychiatr; 2018 Jan; 31():69-70. PubMed ID: 29438922
    [No Abstract]   [Full Text] [Related]  

  • 32. Delusional Parasitosis as a Treatment Complication of Parkinson Disease.
    Ojeda-López C; Aguilar-Venegas LC; Tapia-Orozco M; Cervantes-Arriaga A; Rodríguez-Violante M
    Psychosomatics; 2015; 56(6):696-9. PubMed ID: 26481963
    [No Abstract]   [Full Text] [Related]  

  • 33. Using paliperidone as a monotherapeutic agent on a schizophrenic patient with cirrhosis of the liver.
    Chou HW; Chen CL
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E37. PubMed ID: 23487226
    [No Abstract]   [Full Text] [Related]  

  • 34. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kramer M; Simpson G; Maciulis V; Kushner S; Vijapurkar U; Lim P; Eerdekens M
    J Clin Psychopharmacol; 2007 Feb; 27(1):6-14. PubMed ID: 17224706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 36. Delusional parasitosis: case series of 8 patients and review of the literature.
    Aw DC; Thong JY; Chan HL
    Ann Acad Med Singap; 2004 Jan; 33(1):89-94. PubMed ID: 15008571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paliperidone in the treatment of Tourette's syndrome with comorbid schizophrenia.
    Guan CH; Tsai SJ
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):128. PubMed ID: 23438169
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder.
    Vieta E; Nuamah IF; Lim P; Yuen EC; Palumbo JM; Hough DW; Berwaerts J
    Bipolar Disord; 2010 May; 12(3):230-43. PubMed ID: 20565430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
    Kenchaiah BK; Kumar S; Tharyan P
    Int J Dermatol; 2010 Jan; 49(1):95-100. PubMed ID: 20465623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.